Coconut Oil Treatment for Obesity: Evidence and Guidance
Coconut oil attracts sustained interest as a purported natural intervention for obesity. Marketing claims position it as a metabolism…
-
-
GLP-1 Demand Reshapes the Health and Wellness Startup Landscape
Dealing with chronic health issues inspired Aidan Dewar to explore a new business idea. In 2021, he teamed up…
-
GLP-1 Drugs Drive Down Sales for Gastric Bands and Balloons
Sales for traditional weight loss tools, like gastric bands and balloons, are dropping fast. Experts predict global device sales…
-
Actor Discloses GLP-1 Medication Regimen
Actress Chrissy Metz recently opened up about using a GLP-1 weight loss medication. At first, she was hesitant to…
-
GLP-1 Before Surgery: Anesthesia, Colonoscopy, and Sedation
Glucagon-like peptide-1 receptor agonists have transformed the clinical management of obesity and type 2 diabetes. Medications such as Ozempic,…
-
Is Pomegranate Effective for Weight Loss? Evaluating the Clinical Evidence
Doctors and health experts often talk about using natural foods to support healthy weight management. Pomegranate gets a lot…
-
Novo Nordisk Bumped Up Its Forecast, but Wall Street Is Still Nervous
Novo Nordisk has raised its full-year sales and profit forecasts after reporting a strong second quarter. However, investors were…
-
Consensus Guidelines for Using Incretin Drugs Around Pregnancy
Researchers have published the first comprehensive guide for using incretin-based medications (like GLP-1s) throughout a person’s reproductive life. Published…
-
Eloralintide Phase 2 Results: How a New Weight-Loss Drug Works and Performs
Weight-loss drugs are moving beyond familiar options like Ozempic and Zepbound. A new experimental drug named eloralintide is entering…
-
Eli Lilly and Resilience Boost Manufacturing for Diabetes and Weight-Loss Drugs
Eli Lilly is putting $750 million toward expanding its manufacturing network for drug delivery devices. As part of the…
